Chromosome instability and translocation t(11;18) in primary gastric marginal zone B-cell lymphoma of MALT-type

Hematological Oncology

Volumn 25, Issue 4, 2007, Pages 184-188

  Tibiletti, Maria Grazia ^a   Milani, Katia ^a   Martin, Vittoria ^a,b   Zucca, Emanuele ^c   Motta, Teresio ^d   Cortelazzo, Sergio ^d   Pinotti, Graziella ^a   Mazzucchelli, Luca ^b   Pruneri, Giancarlo ^e   Martinelli, Giovanni ^e   Barbazza, Renzo ^f   Capella, Carlo ^a   Bertoni, Francesco ^c  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b INSTITUTE OF PATHOLOGY   (Switzerland)

^c ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^d OSPEDALI RIUNITI   (Italy)

^e EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^f Servizio di Anatomia Patologica   (Italy)

Author keywords

Antibiotics; API2; FISH; MALT; MALT1; Marginal zone; Stomach

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ONCOPROTEIN; PROTEIN API2; PROTEIN MALT1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER SURVIVAL; CHROMOSOMAL INSTABILITY; CHROMOSOME 18; CHROMOSOME 3; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; STOMACH LYMPHOMA;

BIOPSY; CENTROMERE; CHROMOSOMAL INSTABILITY; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, PAIR 3; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MOLECULAR PROBES; ONCOGENE PROTEINS, FUSION; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE; TRANSLOCATION, GENETIC; TREATMENT OUTCOME;

EID: 37649009187     PISSN: 02780232     EISSN: 10991069     Source Type: Journal    
DOI: 10.1002/hon.825     Document Type: Article

References (26)

1. Isaacson PG, Du MQ. MALT lymphoma: from morphology to molecules. Nat Rev Cancer 2004; 4: 644-653.
2. Zucca E, Bertoni F, Cavalli F. Marginal zone B-cell lymphomas. In The Lymphomas (2nd edn), Canellos GP, Lister TA, Young B (eds). Saunders Elsevier: Philadelphia, PA, USA, 2006; 381-396.
3. Bertoni F, Zucca E. State-of-the-art therapeutics: marginal-zone lymphoma. J Clin Oncol 2005; 23: 6415-6420.
4. Dierlamm J, Baens M, Wlodarska I, et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 1999; 93: 3601-3609.
5. Willis TG, Jadayel DM, Du MQ, et al. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 1999; 96: 35-45.
6. Streubel B, Lamprecht A, Dierlamm J, et al. T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood 2002; 101: 2335-2339.
7. Streubel B, Vinatzer U, Lamprecht A, Raderer M, Chott A. T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia 2005; 19(4): 652-658.
8. Bertoni F, Zucca E. Delving deeper into MALT lymphoma biology. J Clin Invest 2006; 116: 22-26.
9. Farinha P, Gascoyne RD. Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma. J Clin Oncol 2005; 23: 6370-6378.
10. Murga Penas EM, Hinz K, Roser K, et al. Translocations t(11;18)(q21;q21) and t(14;18)(q32;q21) are the main chromosomal abnormalities involving MLT/MALT1 in MALT lymphomas. Leukemia 2003; 17: 2225-2229.
11. Ye H, Liu H, Attygalle A, et al. Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H. pylori in gastric MALT lymphoma. Blood 2003; 102(3): 1012-1018.
12. Dierlamm J, Pittaluga S, Wlodarska I, et al. Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features. Blood 1996; 87: 299-307.
13. Dierlamm J, Rosenberg C, Stul M, et al. Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization. Leukemia 1997; 11: 747-758.
14. Auer IA, Gascoyne RD, Connors JM, et al. t(11;18)(q21;q21) is the most common translocation in MALT lymphomas. Ann Oncol 1997; 8: 979-985.
15. Bertoni F, Conconi A, Capella C, et al. Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial. Blood 2002; 99: 2541-2544.
16. Hancock B, Linch D, Delchier J, et al. Chlorambucil versus observation after anti-Helicobacter therapy in low-grade gastric lymphoma: results of the international LY03 trial. Ann Oncol 2005; 16(Suppl 5): V57.
17. Isaacson PG, Muller-Hermelink HK, Piris MA, et al. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In World Health Organization Classification of Tumours Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). IARC Press: Lyon, 2001; 157-160.
18. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa- associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575-577.
19. Tibiletti MG. Specificity of interphase fluorescence in situ hybridization for detection of chromosome aberrations in tumor pathology. Cancer Genet Cytogenet 2004; 155: 143-148.
20. Shaffer LG, Tommerup N (eds). ISCN (2005): An International System for Human Cytogenetic Nomenclature. S. Karger: Basel, 2005.
21. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998; 396: 643-649.
22. Remstein ED, Kurtin PJ, Einerson RR, Paternoster SF, Dewald GW. Primary pulmonary MALT lymphomas show frequent and heterogeneous cytogenetic abnormalities, including aneuploidy and translocations involving API2 and MALT1 and IGH and MA LT1. Leukemia 2004; 18: 156-160.
23. Bernasconi B, Karamitopoulou E, Tornillo L, et al. Chromosomal instability in Gastric MALT Lymphomas: a FISH study using a tissue microarray approach. Hum Pathol 2007 (in press).
24. Chen F, Castranova V, Shi X. New insights into the role of nuclear factor-kappaB in cell growth regulation. Am J Pathol 2001; 159: 387-397.
25. Hosokawa Y. Anti-apoptotic action of API2-MALT1 fusion protein involved in t(11;18)(q21;q21) MALT lymphoma. Apoptosis 2005; 10: 25-34.
26. Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, et al. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 2001; 357: 39-40.